CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report (CYDY)
The corporate believes any points are resolvable and the BLA resubmission can proceed
CMC and non-clinical sections can be utterly re-submitted as early as September 2021
VANCOUVER, Wash., Aug. 13, 2021 (GLOBE NEWSWIRE) -…